Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro M Machado

Showing results (121-130 of 227) with videos related to

Pageof 23
Sort By:
Rheumatology and Therapy|June 2, 2026
Efficacy of Ixekizumab in Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Level: A Pooled Analysis of Phase III TrialsRaj Sengupta, Pedro M Machado, Philippe Goupille, et al.
RMD Open|October 17, 2025
Utility of repeat MRI in assessing treatment non-response in axial spondyloarthritis: data from two large tertiary rheumatology centresJake Weddell, Ayaan Farah, Rahul Shah, et al.
RMD Open|July 5, 2023
Do fatty lesions explain the effect of inflammation on new syndesmophytes in patients with radiographic axial spondyloarthritis? Results from the SIAS cohort and ASSERT trialRosalinde Stal, Sofia Ramiro, Desirée van der Heijde, et al.
Clinical and Experimental Rheumatology|February 28, 2025
Quantitative muscle magnetic resonance imaging as a biomarker for inclusion body myositis in clinical trials: exploring the in vivo effects of arimoclomolSharfaraz Salam, Jasper M Morrow, Michael P McDermott, et al.
Annals of the Rheumatic Diseases|August 22, 2018
Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritisRicardo J O Ferreira, Mwidimi Ndosi, Maarten de Wit, et al.
Annals of the Rheumatic Diseases|September 7, 2021
SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseasesSaskia Lawson-Tovey, Kimme L Hyrich, Laure Gossec, et al.
Current Rheumatology Reports|November 18, 2014
Ongoing developments in sporadic inclusion body myositisPedro M Machado, Mhoriam Ahmed, Stefen Brady, et al.
Annals of the Rheumatic Diseases|February 13, 2025
1995-2025: thirty years of ASAS and its contribution to the understanding of spondyloarthritisDésirée van der Heijde, Victoria Navarro-Compán, Robert Landewé, et al.
Annals of the Rheumatic Diseases|January 19, 2018
Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trialDésirée van der Heijde, Xenofon Baraliakos, Kay-Geert A Hermann, et al.
Annals of the Rheumatic Diseases|March 28, 2024
Correspondence on 'Current myositis clinical trials and tribulations' by Saygin <i>et al</i>Sofia Ferreira Azevedo, Antonia Valenzuela, Cristian Alejandro Benitez, et al.
Pageof 23

Showing results (121-130 of 227) with videos related to

Sort By:
Pageof 23
Rheumatology and Therapy|June 2, 2026
Efficacy of Ixekizumab in Radiographic Axial Spondyloarthritis by Baseline C-Reactive Protein Level: A Pooled Analysis of Phase III TrialsRaj Sengupta, Pedro M Machado, Philippe Goupille, et al.
RMD Open|October 17, 2025
Utility of repeat MRI in assessing treatment non-response in axial spondyloarthritis: data from two large tertiary rheumatology centresJake Weddell, Ayaan Farah, Rahul Shah, et al.
RMD Open|July 5, 2023
Do fatty lesions explain the effect of inflammation on new syndesmophytes in patients with radiographic axial spondyloarthritis? Results from the SIAS cohort and ASSERT trialRosalinde Stal, Sofia Ramiro, Desirée van der Heijde, et al.
Clinical and Experimental Rheumatology|February 28, 2025
Quantitative muscle magnetic resonance imaging as a biomarker for inclusion body myositis in clinical trials: exploring the in vivo effects of arimoclomolSharfaraz Salam, Jasper M Morrow, Michael P McDermott, et al.
Annals of the Rheumatic Diseases|August 22, 2018
Dual target strategy: a proposal to mitigate the risk of overtreatment and enhance patient satisfaction in rheumatoid arthritisRicardo J O Ferreira, Mwidimi Ndosi, Maarten de Wit, et al.
Annals of the Rheumatic Diseases|September 7, 2021
SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseasesSaskia Lawson-Tovey, Kimme L Hyrich, Laure Gossec, et al.
Current Rheumatology Reports|November 18, 2014
Ongoing developments in sporadic inclusion body myositisPedro M Machado, Mhoriam Ahmed, Stefen Brady, et al.
Annals of the Rheumatic Diseases|February 13, 2025
1995-2025: thirty years of ASAS and its contribution to the understanding of spondyloarthritisDésirée van der Heijde, Victoria Navarro-Compán, Robert Landewé, et al.
Annals of the Rheumatic Diseases|January 19, 2018
Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trialDésirée van der Heijde, Xenofon Baraliakos, Kay-Geert A Hermann, et al.
Annals of the Rheumatic Diseases|March 28, 2024
Correspondence on 'Current myositis clinical trials and tribulations' by Saygin <i>et al</i>Sofia Ferreira Azevedo, Antonia Valenzuela, Cristian Alejandro Benitez, et al.
Pageof 23